000 01520 a2200433 4500
005 20250515032141.0
264 0 _c20060905
008 200609s 0 0 eng d
022 _a1351-5101
024 7 _a10.1111/j.1468-1331.2006.01332.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVos, P E
245 0 0 _aIncreased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity.
_h[electronic resource]
260 _bEuropean journal of neurology
_cJun 2006
300 _a632-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aFemale
650 0 4 _aGlasgow Outcome Scale
650 0 4 _aGlial Fibrillary Acidic Protein
_xblood
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNerve Growth Factors
_xblood
650 0 4 _aPhosphopyruvate Hydratase
_xblood
650 0 4 _aS100 Calcium Binding Protein beta Subunit
650 0 4 _aS100 Proteins
_xblood
650 0 4 _aSeverity of Illness Index
650 0 4 _aStatistics as Topic
650 0 4 _aSubarachnoid Hemorrhage
_xblood
700 1 _avan Gils, M
700 1 _aBeems, T
700 1 _aZimmerman, C
700 1 _aVerbeek, M M
773 0 _tEuropean journal of neurology
_gvol. 13
_gno. 6
_gp. 632-8
856 4 0 _uhttps://doi.org/10.1111/j.1468-1331.2006.01332.x
_zAvailable from publisher's website
999 _c16390005
_d16390005